Rocket Pharmaceuticals
RCKT
RCKT
78 hedge funds and large institutions have $206M invested in Rocket Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 5 closing their positions.
Holders
78
Holders Change
+12
Holders Change %
+18.18%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
29
Reduced
16
Closed
5
Calls
$447K
Puts
$4.08M
Net Calls
-$3.63M
Net Calls Change
-$3.65M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$17.5M |
| 2 |
DCM
2
DAFNA Capital Management
Los Angeles,
California
|
$2.25M |
| 3 |
3
Millennium Management
New York
|
$3.39M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$8.9M |
| 5 |
GTC
5
Ghost Tree Capital
New York
|
$1.61M |
